Cargando…
Is X-linked methyl-CpG binding protein 2 a new target for the treatment of Parkinson's disease
X-linked methyl-CpG binding protein 2 mutations can induce symptoms similar to those of Parkinson's disease and dopamine metabolism disorders, but the specific role of X-linked methyl-CpG binding protein 2 in the pathogenesis of Parkinson's disease remains unknown. In the present study, we...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145902/ https://www.ncbi.nlm.nih.gov/pubmed/25206503 http://dx.doi.org/10.3969/j.issn.1673-5374.2013.21.003 |